GeneDx Holdings Corp.
General ticker "WGS" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $2.8B (TTM average)
GeneDx Holdings Corp. does not follow the US Stock Market performance with the rate: -18.6%.
Estimated limits based on current volatility of 4.0%: low 63.53$, high 68.82$
Factors to consider:
- Earnings expected soon, date: 2026-08-03 bmo
- Total employees count: 1000 as of 2024
- Top business risk factors: Demand not developed, Capital raising failure, Regulatory and compliance, Labor/talent shortage/retention, Supplier concentration
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [43.44$, 120.71$]
- 2025-12-31 to 2026-12-31 estimated range: [26.29$, 77.92$]
Financial Metrics affecting the WGS estimates:
- Negative: with PPE of 258.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -1.37 <= 0.30
- Negative: negative Net income
- Negative: Investing cash flow per share per price, % of -1.45 <= -0.65
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: negative Industry operating income (median)
Short-term WGS quotes
Long-term WGS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $228.38MM | $195.34MM | $302.04MM |
| Operating Expenses | $896.03MM | $375.94MM | $325.26MM |
| Operating Income | $-667.65MM | $-180.60MM | $-23.21MM |
| Non-Operating Income | $69.62MM | $3.90MM | $-29.42MM |
| R&D Expense | $86.20MM | $58.27MM | $45.72MM |
| Income(Loss) | $-598.03MM | $-176.69MM | $-52.63MM |
| Taxes | $-49.05MM | $-0.93MM | $-0.34MM |
| Net Income(Loss)* | $-548.98MM | $-175.77MM | $-52.29MM |
| Stockholders Equity | $253.71MM | $228.02MM | $245.25MM |
| Inventory | $13.66MM | $8.78MM | $10.65MM |
| Assets | $490.94MM | $418.76MM | $419.38MM |
| Operating Cash Flow | $-319.15MM | $-180.15MM | $-28.50MM |
| Capital expenditure | $14.32MM | $5.71MM | $5.49MM |
| Investing Cash Flow | $-141.33MM | $-43.73MM | $-30.13MM |
| Financing Cash Flow | $197.31MM | $186.24MM | $44.16MM |
| Earnings Per Share** | $-53.63 | $-7.23 | $-1.94 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.